{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:35:34Z","timestamp":1775975734135,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10585-021-10089-9","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T03:34:50Z","timestamp":1623123290000},"page":"29-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sentinel lymph node biopsy in melanoma: beyond histologic factors"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6233-4004","authenticated-orcid":false,"given":"Michael J.","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico A.","family":"Monzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6886-4468","authenticated-orcid":false,"given":"Jonathan S.","family":"Zager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"issue":"4","key":"10089_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127(4):392\u2013399. https:\/\/doi.org\/10.1001\/archsurg.1992.01420040034005","journal-title":"Arch Surg"},{"issue":"4","key":"10089_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/00000658-199910000-00001","volume":"230","author":"DL Morton","year":"1999","unstructured":"Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakousis CP, Mozzillo N, Reintgen D, Wang HJ, Glass EC, Cochran AJ (1999) Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230(4):453\u2013463. https:\/\/doi.org\/10.1097\/00000658-199910000-00001Discussion 463-455","journal-title":"Ann Surg"},{"issue":"3","key":"10089_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","volume":"17","author":"JE Gershenwald","year":"1999","unstructured":"Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, Lee JJ, Balch CM, Reintgen DS, Ross MI (1999) Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17(3):976\u2013983. https:\/\/doi.org\/10.1200\/JCO.1999.17.3.976","journal-title":"J Clin Oncol"},{"issue":"7","key":"10089_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang H-J, Elashoff R, Faries MB, Group M (2014) Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 370(7):599\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa1310460","journal-title":"N Engl J Med"},{"issue":"7","key":"10089_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJMe1313690","volume":"370","author":"CM Balch","year":"2014","unstructured":"Balch CM, Gershenwald JE (2014) Clinical value of the sentinel-node biopsy in primary cutaneous melanoma. N Engl J Med 370(7):663\u2013664. https:\/\/doi.org\/10.1056\/NEJMe1313690","journal-title":"N Engl J Med"},{"issue":"11","key":"10089_CR6","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1245\/s10434-014-3954-5","volume":"21","author":"SD Kachare","year":"2014","unstructured":"Kachare SD, Brinkley J, Wong JH, Vohra NA, Zervos EE, Fitzgerald TL (2014) The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma. Ann Surg Oncol 21(11):3377\u20133385. https:\/\/doi.org\/10.1245\/s10434-014-3954-5","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"10089_CR7","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters M, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM (2017) Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med 376(23):2211\u20132222. https:\/\/doi.org\/10.1056\/NEJMoa1613210","journal-title":"N Engl J Med"},{"issue":"6","key":"10089_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/s1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C, Sunderk\u00f6tter C, Kaatz M, Schulte KW, Lehmann P, Vogt T, Ulrich J, Herbst R, Gehring W, Simon JC, Keim U, Martus P, Garbe C (2016) Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol 17(6):757\u2013767. https:\/\/doi.org\/10.1016\/s1470-2045(16)00141-8","journal-title":"Lancet Oncol"},{"issue":"4","key":"10089_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1200\/jco.2017.75.7724","volume":"36","author":"SL Wong","year":"2018","unstructured":"Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH (2018) Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. J Clin Oncol 36(4):399\u2013413. https:\/\/doi.org\/10.1200\/jco.2017.75.7724","journal-title":"J Clin Oncol"},{"issue":"11","key":"10089_CR10","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1245\/s10434-012-2469-1","volume":"19","author":"D Han","year":"2012","unstructured":"Han D, Yu D, Zhao X, Marzban SS, Messina JL, Gonzalez RJ, Cruse CW, Sarnaik AA, Puleo C, Sondak VK, Zager JS (2012) Sentinel node biopsy is indicated for thin melanomas\u2009>\/=0.76 mm. Ann Surg Oncol 19(11):3335\u20133342. https:\/\/doi.org\/10.1245\/s10434-012-2469-1","journal-title":"Ann Surg Oncol"},{"issue":"35","key":"10089_CR11","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","volume":"31","author":"D Han","year":"2013","unstructured":"Han D, Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, Djulbegovic M, Weber JL, Marzban SS, Sondak VK, Messina JL, Vetto JT, White RL, Pockaj B, Mozzillo N, Charney KJ, Avisar E, Krouse R, Kashani-Sabet M, Leong SP (2013) Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol 31(35):4387\u20134393. https:\/\/doi.org\/10.1200\/JCO.2013.50.1114","journal-title":"J Clin Oncol"},{"issue":"13","key":"10089_CR12","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1245\/s10434-016-5137-z","volume":"23","author":"E Cordeiro","year":"2016","unstructured":"Cordeiro E, Gervais MK, Shah PS, Hong NJ, Wright FC (2016) Sentinel lymph node biopsy in thin cutaneous melanoma: a systematic review and meta-analysis. Ann Surg Oncol 23(13):4178\u20134188. https:\/\/doi.org\/10.1245\/s10434-016-5137-z","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10089_CR13","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1002\/cam4.2358","volume":"8","author":"A Tejera-Vaquerizo","year":"2019","unstructured":"Tejera-Vaquerizo A, Ribero S, Puig S, Boada A, Paradela S, Moreno-Ramirez D, Canueto J, de Unamuno B, Brinca A, Descalzo-Gallego MA, Osella-Abate S, Cassoni P, Carrera C, Vidal-Sicart S, Bennassar A, Rull R, Alos L, Requena C, Bolumar I, Traves V, Pla A, Fernandez-Orland A, Jaka A, Fernandez-Figueres MT, Hilari JM, Gimenez-Xavier P, Vieira R, Botella-Estrada R, Roman-Curto C, Ferrandiz L, Iglesias-Pena N, Ferrandiz C, Malvehy J, Quaglino P, Nagore E, Grp S (2019) Survival analysis and sentinel lymph node status in thin cutaneous melanoma: a multicenter observational study. Cancer Med 8(9):4235\u20134244. https:\/\/doi.org\/10.1002\/cam4.2358","journal-title":"Cancer Med"},{"issue":"4","key":"10089_CR14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1245\/s10434-018-6348-2","volume":"25","author":"TD Murtha","year":"2018","unstructured":"Murtha TD, Han G, Han D (2018) Predictors for use of sentinel node biopsy and the association with improved survival in melanoma patients who have nodal staging. Ann Surg Oncol 25(4):903\u2013911. https:\/\/doi.org\/10.1245\/s10434-018-6348-2","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10089_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jamcollsurg.2018.12.030","volume":"228","author":"ME Egger","year":"2019","unstructured":"Egger ME, Stevenson M, Bhutiani N, Jordan AC, Scoggins CR, Philips P, Martin RC 2nd, McMasters KM (2019) Should sentinel lymph node biopsy be performed for all T1b melanomas in the new 8(th) edition american joint committee on cancer staging system? J Am Coll Surg 228(4):466\u2013472. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2018.12.030","journal-title":"J Am Coll Surg"},{"issue":"12","key":"10089_CR16","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1245\/s10434-019-07690-4","volume":"26","author":"ME Egger","year":"2019","unstructured":"Egger ME, Stevenson M, Bhutiani N, Jordan AC, Scoggins CR, Philips P, Martin RCG 2nd, McMasters KM (2019) Age and lymphovascular invasion accurately predict sentinel lymph node metastasis in T2 melanoma patients. Ann Surg Oncol 26(12):3955\u20133961. https:\/\/doi.org\/10.1245\/s10434-019-07690-4","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10089_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jaad.2018.08.022","volume":"80","author":"AN Hanna","year":"2019","unstructured":"Hanna AN, Sinnamon AJ, Roses RE, Kelz RR, Elder DE, Xu X, Pockaj BA, Zager JS, Fraker DL, Karakousis GC (2019) Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00\u00a0mm): a National Cancer Database study. J Am Acad Dermatol 80(2):433\u2013440. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.022","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10089_CR18","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1200\/jco.2010.33.1884","volume":"29","author":"ME Valsecchi","year":"2011","unstructured":"Valsecchi ME, Silbermins D, de Rosa N, Wong SL, Lyman GH (2011) Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol 29(11):1479\u20131487. https:\/\/doi.org\/10.1200\/jco.2010.33.1884","journal-title":"J Clin Oncol"},{"issue":"4","key":"10089_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.6004\/jnccn.2019.0018","volume":"17","author":"DG Coit","year":"2019","unstructured":"Coit DG, Thompson JA, Albertini MR, Barker C, Carson WE, Contreras C, Daniels GA, DiMaio D, Fields RC, Fleming MD, Freeman M, Galan A, Gastman B, Guild V, Johnson D, Joseph RW, Lange JR, Nath S, Olszanski AJ, Ott P, Gupta AP, Ross MI, Salama AK, Skitzki J, Sosman J, Swetter SM, Tanabe KK, Wuthrick E, McMillian NR, Engh AM (2019) Cutaneous melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in oncology. J Natl Compr Cancer Netw 17(4):367\u2013402. https:\/\/doi.org\/10.6004\/jnccn.2019.0018","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"10089_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.amjsurg.2010.01.019","volume":"199","author":"MC Ellis","year":"2010","unstructured":"Ellis MC, Weerasinghe R, Corless CL, Vetto JT (2010) Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes. Am J Surg 199(5):663\u2013668. https:\/\/doi.org\/10.1016\/j.amjsurg.2010.01.019","journal-title":"Am J Surg"},{"issue":"9","key":"10089_CR21","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1245\/s10434-014-3758-7","volume":"21","author":"ZM Bamboat","year":"2014","unstructured":"Bamboat ZM, Konstantinidis IT, Kuk D, Ariyan CE, Brady MS, Coit DG (2014) Observation after a positive sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol 21(9):3117\u20133123. https:\/\/doi.org\/10.1245\/s10434-014-3758-7","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10089_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s11845-017-1559-2","volume":"186","author":"KM Joyce","year":"2017","unstructured":"Joyce KM, McInerney NM, Piggott RP, Martin F, Jones DM, Hussey AJ, Kerin MJ, Kelly JL, Regan PJ (2017) Analysis of sentinel node positivity in primary cutaneous melanoma: an 8-year single institution experience. Ir J Med Sci 186(4):847\u2013853. https:\/\/doi.org\/10.1007\/s11845-017-1559-2","journal-title":"Ir J Med Sci"},{"issue":"2","key":"10089_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejso.2016.06.407","volume":"43","author":"JA Moody","year":"2017","unstructured":"Moody JA, Ali RF, Carbone AC, Singh S, Hardwicke JT (2017) Complications of sentinel lymph node biopsy for melanoma\u2014a systematic review of the literature. Eur J Surg Oncol 43(2):270\u2013277. https:\/\/doi.org\/10.1016\/j.ejso.2016.06.407","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10089_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","volume":"21","author":"P Gerami","year":"2015","unstructured":"Gerami P, Cook RW, Wilkinson J, Russell MC, Dhillon N, Amaria RN, Gonzalez R, Lyle S, Johnson CE, Oelschlager KM, Jackson GL, Greisinger AJ, Maetzold D, Delman KA, Lawson DH, Stone JF (2015) Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma. Clin Cancer Res 21(1):175\u2013183. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-3316","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10089_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.25251\/skin.3.4.2","volume":"3","author":"E Marks","year":"2019","unstructured":"Marks E, Caruso HG, Kurley SJ, Ibad S, Plasseraud KM, Monzon FA, Cockerell CJ (2019) Establishing an evidence-based decision point for clinical use of the 31-gene expression profile test in cutaneous melanoma. SKIN J Cutan Med 3(4):239\u2013249. https:\/\/doi.org\/10.25251\/skin.3.4.2","journal-title":"SKIN J Cutan Med"},{"issue":"4","key":"10089_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hed.25473","volume":"41","author":"BR Gastman","year":"2019","unstructured":"Gastman BR, Zager JS, Messina JL, Cook RW, Covington KR, Middlebrook B, Gerami P, Wayne JD, Leachman S, Vetto JT (2019) Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck. Head Neck 41(4):871\u2013879. https:\/\/doi.org\/10.1002\/hed.25473","journal-title":"Head Neck"},{"issue":"1","key":"10089_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12885-018-4016-3","volume":"18","author":"JS Zager","year":"2018","unstructured":"Zager JS, Gastman BR, Leachman S, Gonzalez RC, Fleming MD, Ferris LK, Ho J, Miller AR, Cook RW, Covington KR, Meldi-Plasseraud K, Middlebrook B, Kaminester LH, Greisinger A, Estrada SI, Pariser DM, Cranmer LD, Messina JL, Vetto JT, Wayne JD, Delman KA, Lawson DH, Gerami P (2018) Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients. BMC Cancer 18(1):130. https:\/\/doi.org\/10.1186\/s12885-018-4016-3","journal-title":"BMC Cancer"},{"issue":"5","key":"10089_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jaad.2015.01.009","volume":"72","author":"P Gerami","year":"2015","unstructured":"Gerami P, Cook RW, Russell MC, Wilkinson J, Amaria RN, Gonzalez R, Lyle S, Jackson GL, Greisinger AJ, Johnson CE, Oelschlager KM, Stone JF, Maetzold DJ, Ferris LK, Wayne JD, Cooper C, Obregon R, Delman KA, Lawson D (2015) Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy. J Am Acad Dermatol 72(5):780\u2013785. https:\/\/doi.org\/10.1016\/j.jaad.2015.01.009","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10089_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13000-018-0690-3","volume":"13","author":"RW Cook","year":"2018","unstructured":"Cook RW, Middlebrook B, Wilkinson J, Covington KR, Oelschlager K, Monzon FA, Stone JF (2018) Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients. Diagn Pathol 13(1):13. https:\/\/doi.org\/10.1186\/s13000-018-0690-3","journal-title":"Diagn Pathol"},{"issue":"5","key":"10089_CR30","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1002\/cam4.2128","volume":"8","author":"J Keller","year":"2019","unstructured":"Keller J, Schwartz TL, Lizalek JM, Chang ES, Patel AD, Hurley MY, Hsueh EC (2019) Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma. Cancer Med 8(5):2205\u20132212. https:\/\/doi.org\/10.1002\/cam4.2128","journal-title":"Cancer Med"},{"issue":"5","key":"10089_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/jdv.15454","volume":"33","author":"S Podlipnik","year":"2019","unstructured":"Podlipnik S, Carrera C, Boada A, Richarz NA, Lopez-Estebaranz JL, Pinedo-Moraleda F, Elosua-Gonzalez M, Martin-Gonzalez MM, Carrillo-Gijon R, Redondo P, Moreno E, Malvehy J, Puig S (2019) Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients. A prospective multicentre cohort study. J Eur Acad Dermatol Venereol 33(5):857\u2013862. https:\/\/doi.org\/10.1111\/jdv.15454","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10089_CR32","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1097\/DSS.0000000000001588","volume":"44","author":"BN Greenhaw","year":"2018","unstructured":"Greenhaw BN, Zitelli JA, Brodland DG (2018) Estimation of prognosis in invasive cutaneous melanoma: an independent study of the accuracy of a gene expression profile test. Dermatol Surg 44(12):1494\u20131500. https:\/\/doi.org\/10.1097\/DSS.0000000000001588","journal-title":"Dermatol Surg"},{"issue":"1","key":"10089_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13045-017-0520-1","volume":"10","author":"EC Hsueh","year":"2017","unstructured":"Hsueh EC, DeBloom JR, Lee J, Sussman JJ, Covington KR, Middlebrook B, Johnson C, Cook RW, Slingluff CL Jr, McMasters KM (2017) Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test. J Hematol Oncol 10(1):152. https:\/\/doi.org\/10.1186\/s13045-017-0520-1","journal-title":"J Hematol Oncol"},{"issue":"11","key":"10089_CR34","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2217\/fon-2018-0912","volume":"15","author":"JT Vetto","year":"2019","unstructured":"Vetto JT, Hsueh EC, Gastman BR, Dillon LD, Monzon FA, Cook RW, Keller J, Huang X, Fleming A, Hewgley P, Gerami P, Leachman S, Wayne JD, Berger AC, Fleming MD (2019) Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling. Future Oncol 15(11):1207\u20131217. https:\/\/doi.org\/10.2217\/fon-2018-0912","journal-title":"Future Oncol"},{"issue":"1","key":"10089_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaad.2018.07.028","volume":"80","author":"BR Gastman","year":"2019","unstructured":"Gastman BR, Gerami P, Kurley SJ, Cook RW, Leachman S, Vetto JT (2019) Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria. J Am Acad Dermatol 80(1):149\u2013157. https:\/\/doi.org\/10.1016\/j.jaad.2018.07.028","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10089_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.25251\/skin.2.2.3","volume":"2","author":"LD Dillon","year":"2018","unstructured":"Dillon LD, Gadzia JE, Davidson RS, McPhee M, Covington KR, Cook RW, Johnson C, Monzon FA, Milanese ED, Vetto J, Jarell AD, Fleming MD (2018) Prospective, multicenter clinical impact evaluation of a 31-gene expression profile test for management of melanoma patients. SKIN J Cutan Med 2(2):111\u2013121. https:\/\/doi.org\/10.25251\/skin.2.2.3","journal-title":"SKIN J Cutan Med"},{"issue":"7","key":"10089_CR37","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1245\/s10434-015-4538-8","volume":"22","author":"MW Cavanaugh-Hussey","year":"2015","unstructured":"Cavanaugh-Hussey MW, Mu EW, Kang S, Balch CM, Wang T (2015) Older age is associated with a higher incidence of melanoma death but a lower incidence of sentinel lymph node metastasis in the SEER databases (2003-2011). Ann Surg Oncol 22(7):2120\u20132126. https:\/\/doi.org\/10.1245\/s10434-015-4538-8","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10089_CR38","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jamadermatol.2017.2497","volume":"153","author":"AJ Sinnamon","year":"2017","unstructured":"Sinnamon AJ, Neuwirth MG, Yalamanchi P, Gimotty P, Elder DE, Xu X, Kelz RR, Roses RE, Chu EY, Ming ME, Fraker DL, Karakousis GC (2017) Association between patient age and lymph node positivity in thin melanoma. JAMA Dermatol 153(9):866\u2013873. https:\/\/doi.org\/10.1001\/jamadermatol.2017.2497","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10089_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1245\/aso.2004.03.044","volume":"11","author":"VK Sondak","year":"2004","unstructured":"Sondak VK, Taylor JM, Sabel MS, Wang Y, Lowe L, Grover AC, Chang AE, Yahanda AM, Moon J, Johnson TM (2004) Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11(3):247\u2013258. https:\/\/doi.org\/10.1245\/aso.2004.03.044","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10089_CR40","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1245\/s10434-013-3100-9","volume":"20","author":"CM Balch","year":"2013","unstructured":"Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Coit DG, Atkins MB, Ding S, Cochran AJ, Eggermont AM, Flaherty KT, Gimotty PA, Johnson TM, Kirkwood JM, Leong SP, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sondak VK (2013) Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol 20(12):3961\u20133968. https:\/\/doi.org\/10.1245\/s10434-013-3100-9","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10089_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin 67(2):93\u201399","journal-title":"CA Cancer J Clin"},{"key":"10089_CR42","doi-asserted-by":"crossref","unstructured":"Prado G, Teplitz RW, Covington KR, Caruso HG, Cook RW, Rigel DS (2019) The prognostic 31-gene expression profile (31-GEP) test improves risk prediction in cutaneous melanoma (CM) patients within current AJCC stages. Poster at 2019 Fall Clinical Dermatology Conference for PAs and NPs: May 31\u2013June 2, 2019, Scottsdale, Arizona","DOI":"10.25251\/skin.2.supp.70"},{"issue":"3","key":"10089_CR43","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jaad.2020.03.053","volume":"83","author":"BN Greenhaw","year":"2020","unstructured":"Greenhaw BN, Covington KR, Kurley SJ, Yeniay Y, Cao NA, Plasseraud KM, Cook RW, Hsueh EC, Gastman BR, Wei ML (2020) Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients. J Am Acad Dermatol 83(3):745\u2013753. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.053","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10089_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.25251\/skin.4.3.3","volume":"4","author":"GH Litchman","year":"2020","unstructured":"Litchman GH, Prado G, Teplitz RW, Rigel D (2020) A systematic review and meta-analysis of gene expression profiling for primary cutaneous melanoma prognosis. SKIN J Cutan Med 4(3):221\u2013237. https:\/\/doi.org\/10.25251\/skin.4.3.3","journal-title":"SKIN J Cutan Med"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-021-10089-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-021-10089-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:50:01Z","timestamp":1648615801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-021-10089-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10089"],"URL":"https:\/\/doi.org\/10.1007\/s10585-021-10089-9","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.J.C. has no conflicts of interest to disclose. F.A.M. is a former employee and current stock option holder at Castle Biosciences, Inc. J.S.Z. has advisory board relationships with Novartis, Sanofi\/Regeneron, Merck; receives research funding from Amgen, Delcath Systems, Philogen, Provectus; consults for Castle Biosciences and Philogen, speaker\u2019s bureau for Castle Biosciences, Pfizer and SunPharma. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}